PENEDERM NDA FILINGS FOR RETINOIC ACID GEL AND CREAM FOR ACNE
Executive Summary
PENEDERM NDA FILINGS FOR RETINOIC ACID GEL AND CREAM FOR ACNE are pending at FDA, the company indicates in a May 2 "red herring" prospectus for 1.7 mil. shares of common stock being sold by Penederm shareholders. Foster City, Calif.-based Penederm said that Phase III trials that enrolled about 400 subjects were completed in the summer of 1993, and both NDAs were originally submitted in September. Resubmissions were made in March with additional data after initial discussions with FDA.